Dendritic Cell Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ERNA | D | Eterna Therapeutics Inc. | -3.04 | |
CLDX | F | Celldex Therapeutics, Inc. | -4.83 |
Related Industries: Biotechnology Broadcasting - TV
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | B | ALPS Medical Breakthroughs ETF | 1.54 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 0.82 | |
XBI | B | SPDR S&P Biotech ETF | 0.78 | |
BTEC | B | Principal Healthcare Innovators Index ETF | 0.5 | |
LABU | C | Direxion Daily S&P Biotech Bull 3X Shares | 0.45 |
Compare ETFs
- Dendritic Cell
Dendritic cells (DCs) are antigen-presenting cells (also known as accessory cells) of the mammalian immune system. Their main function is to process antigen material and present it on the cell surface to the T cells of the immune system. They act as messengers between the innate and the adaptive immune systems.
Dendritic cells are present in those tissues that are in contact with the external environment, such as the skin (where there is a specialized dendritic cell type called the Langerhans cell) and the inner lining of the nose, lungs, stomach and intestines. They can also be found in an immature state in the blood. Once activated, they migrate to the lymph nodes where they interact with T cells and B cells to initiate and shape the adaptive immune response. At certain development stages they grow branched projections, the dendrites that give the cell its name (δένδρον or déndron being Greek for 'tree'). While similar in appearance, these are structures distinct from the dendrites of neurons. Immature dendritic cells are also called veiled cells, as they possess large cytoplasmic 'veils' rather than dendrites.
Popular Now
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles